Share chart Aladdin Healthcare Technologies SE
Extended chart
Simple chart
About
Aladdin Healthcare Technologies SE, through its subsidiary, Aladdin Healthcare Technologies Ltd, develops software solutions for the storage and management of health information using blockchain technology. The company provides Artificial Intelligence assisted Drug Discovery platform to identify various small molecule drug compounds with multiple age-related diseases, including Alzheimer's, Parkinson's, and SARS-CoV-2; PharmaKG, a biomedical knowledge graph; and Disease Diagnosis and Risk Assessment Platform. The company was founded in 2014 and is based in Berlin, Germany.
| Change price per day: |
+0% (0.014) |
| Change price per week: |
+0% (0.014) |
| Change price per month: |
+0% (0.014) |
| Change price per 3 month: |
+0% (0.014) |
| Change price per half year: |
+0% (0.014) |
| Change price per year: |
+0% (0.014) |
| Change price per 3 year: |
-95.41% (0.305) |
| Change price per 5 year: |
+0% (0.014) |
| Change price per 10 year: |
+0% (0.014) |
| Change price per year to date: |
+0% (0.014) |
|
|
Underestimation
| Title |
Value |
Grade |
| P/S |
0 |
0 |
| P/BV |
0 |
0 |
| P/E |
0 |
0 |
| EV/EBITDA |
0 |
0 |
| Total: |
|
2.5 |
|
Efficiency
| Title |
Value |
Grade |
| ROA, % |
0 |
0 |
| ROE, % |
0 |
0 |
| Total: |
|
0 |
|
|
|
Dividends
| Title |
Value |
Grade |
| Div yield, % |
0 |
0 |
| DSI |
0 |
0 |
| Total: |
|
0 |
|
Debt
| Title |
Value |
Grade |
| Debt/EBITDA |
0 |
10 |
| Total: |
|
10 |
|
Growth impulse
| Title |
Value |
Grade |
| Yield Revenue, % |
0 |
0 |
| Yield Ebitda, % |
1264.44 |
10 |
| Yield EPS, % |
-108.92 |
0 |
| Total: |
|
6 |
|
| Head |
Job title |
Payment |
Year of birth |
| Mr. Wade Menpes-Smith |
Chairman of the Board, CEO & MD |
|
|
| Mr. Bimal Shah |
Deputy Chairman & COO |
|
|
| Mr. Hamish Badenoch |
CFO & Director |
|
|
| Prof. David C. Rubinsztein |
Member of Drug Discovery Advisory Board & Chief Scientific Advisor |
|
|
| Mr. Paul Sitoh |
Head of Blockchain Technology |
|
|
